A simultaneous combined pancreatic test can be performed in one morning with only one intubation of the duodenum. The test includes the measurement of exocrine pancreatic secretion of bicarbonate, enzymes, and radioactive selenium, pancreatic scanning, hypotonic duodenography, and cytology of the duodenal aspirate. In the first 70 patients it was found that a single secretion test was of only limited value in detecting pancreatic disease; cytology was the most reliable and scanning the least reliable single test; and that the combined test provided near-complete discrimination between patients with no pancreatic disease, with chronic pancreatitis, and with carcinoma of the pancreas.
Introduction
None of the many methods available for investigating patients for pancreatic disease are satisfactory. Not only is it difficult to distinguish between different diseases of the pancreas but it is often impossible to state whether the pancreas is normal or abnormal. To try to improve the accuracy of diagnosis three different pancreatic tests have been made simultaneously (Bourke et al., 1972; Youngs et al., 1973) . We have combined in one morning, with only one intubation of the duodenum and
Patients and Methods
The patient fasted overnight and the duodenum was intubated under fluoroscopic control with a double-lumen Dreiling tube, the tip being positioned at the duodenojejunal flexure. The stomach was aspirated continuously with a pump and the aspirate discarded. The duodenum was aspirated continuously with a separate pump for three hours in 12 collection periods of 15 minutes duration.
Afterbasalaspirationfor30minutes secretin GIH 0 25 U/kg/hr, and pancreozymin GIH 16 U/kg/hr (Crick-Harper-Raper) were infused intravenously in 0 9% saline for 90 minutes. This combined hormone infusion evokes near-maximal output of bicarbonate and enzymes (Wormsley, 1969) . A single intravenous injection of 75Se-selenomethionine 3 ,uCi/kg (Radiochemical Centre, Amersham) was given at the same time. This labelled amino-acid is probably incorporated into all the pancreatic enzymes, so that the selenium count in the duodenal aspirate is an index of total enzyme output (Youngs et al., 1971) . The pancreas was scanned simultaneously using a Nuclear Chicago PHO/gamma camera.
At the end of these tests hypotonic duodenography was carried out using intravenous propantheline 30 mg and x-ray pictures taken by a standard double-contrast technique (Raia and Kreel, 1966; Stage and Banks, 1969) . The duodenal aspirates were analysed for volume, bicarbonate concentration, and tryptic activity by the methods of Gutierrez and Baron (1972 Of the remaining three patients, one had a hormoneproducing pancreatic tumour (Elias et al., 1972) and two had inadequate follow-up data.
Results
The results in these 67 patients were examined with a view to assessing, firstly, the usefulness of an individual secretion test in distinguishing between groups of patients with different pancreatic diseases; secondly, the reliability of each single test; and, thirdly, the usefulness of the combined test.
USEFULNESS OF SINGLE SECRETION TEST
There was no significant difference between the means of the plateau bicarbonate output (expressed as the sum of the two highest consecutive bicarbonate outputs after hormonal stimu- bicarbonate concentration, and enzyme output after stimulation with a single intravenous injection of 1 U/kg of secretin (Boots) in over 5,000 tests provided a diagnostic accuracy of just under 90%. The experience of other workers (Bank et al., 1963; Wormsley, 1968) , admittedly from fewer tests, has been different.
In the present series a single secretion test was of only limited diagnostic value. Half of our patients with no pancreatic disease had plateau bicarbonate outputs below 30 mEq/hr, an output regarded by Wormsley (1969) as the lower limit of the normal pancreas. Wormsley (1970) suggested that patients with outputs below 30 mEq/hr in response to his combined infusion of secretin 0-25 U/kg/hr and pancreozymin 16 U/kg/hr should be retested with a near-maximum dose of secretin 2 U/kg/hr alone to determine whether the pancreas is merely insensitive to the lower dose of stimulant or incapable of stimulation even by the higher dose. We have not retested patients with no pancreatic disease or those with pancreatitis, nor are we convinced that a maximum dose of stimulant will necessarily provide greater diagnostic discrimination than a submaximum dose (Gutierrez and Baron, 1972) .
Other workers have suggested that near-maximum stimulation of the pancreas is a disadvantage in pancreatic scanning (Sodee, 1964) . Except for two recovering from recent acute pancreatitis, all of the patients with an abnormal pancreas had a technically unsatisfactory or abnormal scan. However, only 18 of the 33 patients with a normal pancreas had a normal scan. Other workers McCready and Cottrall, 1971; McCarthy et al., 1972; Agnew et al., 1973) have pointed out that non-pancreatic conditions could cause abnormalities in scanning, including postgastrectomy/vagotomy, peptic ulceration, metastatic disease, cirrhosis, and diabetes mellitus. Many patients with a normal pancreas studied in this series had one of the above conditions. Thus while a normal scan argues strongly against the presence of pancreatic disease, an abnormal scan may be misleading McCarthy and Brown, 1969; McCarthy et al., 1972; Braganza et al., 1973; Youngs et al., 1973) .
Pancreatic cytology for carcinoma has been stated to have an accuracy of between 37% (Rankin and Brown, 1964) and 90% (Asnaes and Johansen, 1970 The value of using a combination of tests was therefore assessed. Bourke et al. (1972) found that a triple combination gave quicker and better diagnostic results in 75 jaundiced patients. In the present study the group with suspected pancreatic disease included both jaundiced and non-jaundiced patients. Those in the group with no pancreatic disease mostly had abdominal pain as their predominant symptom, but they were judged to have no pancreatic disease if the pain had disappeared on follow-up or another cause for it was found. This group, therefore, probably included patients with minor but possibly clinical irrelevant abnormalities of pancreatic structure and function. The one patient with the low score had abdominal pain at the time of the test but no other evidence of pancreatic disease, and has remained symptom-free since. The patients with chronic pancreatitis had gross disease and in all patients with carcinoma the diagnosis was confirmed at laparotomy. In this small series, and especially in cases of advanced disease, the combined test provided better discrimination between the groups of patients studied than single tests used alone. To measure the cost-effectiveness of the combined test was more 0 . difficult, since it did not obviate the need for laparotomy. Of the 12 patients with jaundice on whom the test was carried out five had stones in the common bile duct, two had carcinoma of the hepatic duct, and five had carcinoma of the head of the pancreas. Cytological examination predicted the presence or absence of carcinoma with considerable accuracy.
The triple test failed to diagnose carcinoma in one-third of the patients by the two intubation tests, and the abnormal pancreatic scans were not in themselves diagnostic of carcinoma. In the present study the additional information obtained from duodenography and cytology resulted in a correct diagnosis of carcinoma in all but one patient. A preoperative diagnosis of carcinoma of the pancreas allows suitable adjustment of preoperative preparation and also obviates the need for biopsy of a pancreatic mass, which may be misleading and dangerous. With increasing experience we hope that the accuracy of preoperative diagnosis will be improved further.
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